Butyl 4-isocyanatobenzoate → HCID 57559150, compound
Reaction equation
[CH2:1]([O:3][C:4]([C:6]1[C:12]2[NH:13][C:14]3[CH:15]=[CH:16][CH:17]=[CH:18][C:19]=3[C:11]=2[CH2:10][CH2:9][NH:8][CH:7]=1)=[O:5])[CH3:2].[C:20]([C:27]1[CH:32]=[CH:31][C:30]([N:33]=[C:34]=[O:35])=[CH:29][CH:28]=1)([O:22][CH2:23][CH2:24][CH2:25][CH3:26])=[O:21]>>[CH2:1]([O:3][C:4]([C:6]1[C:12]2[NH:13][C:14]3[CH:15]=[CH:16][CH:17]=[CH:18][C:19]=3[C:11]=2[CH2:10][CH2:9][N:8]([C:34](=[O:35])[NH:33][C:30]2[CH:29]=[CH:28][C:27]([C:20]([O:22][CH2:23][CH2:24][CH2:25][CH3:26])=[O:21])=[CH:32][CH:31]=2)[CH:7]=1)=[O:5])[CH3:2]Participants
3
Procedure
The title compound was prepared in a manner similar to that described in Example 72 by using ethyl-1,2,3,6-tetrahydroazepino[4,5-b]indole-5-carboxylate and 4-(carbobutoxy)phenyl isocyanate (˜2.0 mg); MS (ES): 476 (MH+).
Sources & evidence
- ORD record
- ord-c685c562beb84853bb9144404c751326
- Source dataset
- uspto-grants-2009_02
- Patent number
- US07485634B2
Reaction notes
Loading…